INSMED Executives Conduct Series of Stock Transactions
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Lewis William | Chair and CEO | Sell | $878,292 | Form 4 |
| Mcgirr David W J | Director | Sell | $451,535 | Form 4 |
| Schaeffer Orlov S Nicole | Chief People Strategy Officer | Sell | $117,403 | Form 4 |
| Bonstein Sara | Chief Financial Officer | Sell | $112,898 | Form 4 |
| Adsett Roger | Chief Operating Officer | Sell | $132,990 | Form 4 |
| Flammer Martina M.D. | Chief Medical Officer | Sell | $120,549 | Form 4 |
| Smith Michael Alexander | Chief Legal Officer | Sell | $103,532 | Form 4 |
INSMED has seen a flurry of stock transactions by its top executives, as reported in recent SEC Form 4 filings. Chair and CEO William Lewis sold 12,302 shares at weighted average prices between $70.23 and $71.94, totaling $878,292. Following these sales, Lewis's direct ownership stands at 308,758 shares, with an additional 284,424 shares held indirectly.
Director David W J McGirr sold 6,250 shares at weighted average prices of $71.3 and $73.27, totaling $451,535. McGirr now directly owns 97,723 shares.
Chief People Strategy Officer Schaeffer Orlov S Nicole sold 1,642 shares at $71.5 each, totaling $117,403, to cover tax obligations from Restricted Stock Units (RSUs), leaving her with 118,579 shares.
Chief Financial Officer Sara Bonstein also sold 1,579 shares at $71.5 each, totaling $112,898, for tax obligations related to RSUs, with her direct ownership now at 113,288 shares.
Chief Operating Officer Roger Adsett sold 1,860 shares at $71.5 each, totaling $132,990, to cover similar tax obligations, now directly owning 141,323 shares.
Chief Medical Officer Martina M.D. Flammer sold 1,686 shares at $71.5 each, totaling $120,549, for tax obligations, with her direct ownership at 83,111 shares.
Chief Legal Officer Michael Alexander Smith sold 1,448 shares at $71.5 each, totaling $103,532, to satisfy tax obligations from RSUs, with his direct ownership now at 69,597 shares.